secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xilio Therapeutics, Inc. (XLO)
CIK:        0001840233
Form:       8-K
Filed at:   2022-12-23T23:59:59+00:00
Accession:  0001544784-22-000009
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Xilio Therapeutics VP and principal accounting officer Edward C. English resigns effective Jan 31, 2023
--------------------------------------------------------------------------------

- Edward C. English notified his resignation as VP, finance, accounting, treasury, and principal accounting officer.
- Departure effective January 31, 2023, to pursue other opportunities.
- No successor or interim replacement disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840233/000154478422000009/0001544784-22-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840233/000154478422000009/xlo-20221219x8k.htm
  HTML page:      https://secwatch.observer/filing/0001544784-22-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer